Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology lead asset, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases.

TSX:SVA - Post by User

Sernova Corp > SVA is up almost 70% in a month, will the rise continue???

<< Previous

Bullboard Posts

Next >>

Comment by Markhamjohnon Jan 07, 2022 8:59am

222 Views

Post# 34292179

RE:SVA is up almost 70% in a month, will the rise continue???

rixpix wrote: We all know this huge increase is in anticipation of great news coming out Monday.

But will the rise continue after news is out, or is this news already priced in to the increase??

We all know that the potential to becme a multi billion dollar company exists and the future looks very bright.

But what will happen Monday is the billion $ question.

In my opinion the general public is completely unaware of Sernova and the scientific advances made to date. If the news is quite good next week and if the Major TV networks see it as a worthwhile story then the promise of a possible cure on the National News will create enough buying interest to absorb the activities of the "sell on news" crowd and propel the stock significantly higher.

<< Previous

Bullboard Posts

Next >>

Revolutionizing medical imaging with nanocarbon-based contrast drugs